Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating
MT NewswiresFeb 9 09:00 ET
Oppenheimer Keeps Their Hold Rating on Enanta Pharmaceuticals (ENTA)
TipRanksFeb 9 07:58 ET
Maintaining Hold on Enanta Pharmaceuticals Amid Near-Term Challenges and Pipeline Potential
TipRanksFeb 9 00:51 ET
Enanta Pharma Analyst Ratings
BenzingaFeb 8 16:42 ET
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Arrowhead Pharmaceuticals (ARWR)
TipRanksFeb 8 08:10 ET
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Enanta Pharmaceuticals (ENTA) and Steris (STE)
TipRanksFeb 8 00:30 ET
Analysts Are Bullish on These Healthcare Stocks: Enanta Pharmaceuticals (ENTA), Spruce Biosciences (SPRB)
TipRanksJan 9 01:21 ET
Analysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN), Enanta Pharmaceuticals (ENTA) and Synlogic (SYBX)
TipRanksJan 9 01:01 ET
Analysts Are Bullish on These Healthcare Stocks: Black Diamond Therapeutics (BDTX), Enanta Pharmaceuticals (ENTA)
TipRanksJan 5 06:30 ET
Buy Rating on Enanta Pharmaceuticals Amidst Promising RSV Program Developments and Strategic Expansion Into CSU Market
TipRanksJan 4 14:35 ET
Enanta Pharma Analyst Ratings
BenzingaNov 22, 2023 13:46 ET
Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $21 From $25, Maintains Perform Rating
MT NewswiresNov 22, 2023 09:43 ET
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Enanta Pharmaceuticals (ENTA) and Arvinas Holding Company (ARVN)
TipRanksNov 22, 2023 07:20 ET
Hold Rating on Enanta Pharmaceuticals: A Comprehensive Analysis of Future Prospects and Challenges
TipRanksNov 22, 2023 06:38 ET
JMP Securities Maintains Outperform on Enanta Pharma, Lowers Price Target to $23
BenzingaNov 21, 2023 06:51 ET
Enanta Pharma Analyst Ratings
BenzingaNov 21, 2023 06:49 ET
Analysts Offer Insights on Healthcare Companies: Morphosys Ag (MOR) and Enanta Pharmaceuticals (ENTA)
TipRanksNov 21, 2023 00:31 ET
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Enanta Pharmaceuticals (ENTA) and BioMarin Pharmaceutical (BMRN)
TipRanksOct 25, 2023 02:40 ET
HC Wainwright & Co. Maintains Buy on Enanta Pharma, Lowers Price Target to $30
BenzingaOct 23, 2023 07:07 ET
Enanta Pharma Analyst Ratings
BenzingaOct 23, 2023 07:06 ET
No Data
No Data